.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Farmers Insurance
Fish and Richardson
Cipla
Accenture
Federal Trade Commission
Citi
Cantor Fitzgerald
Boehringer Ingelheim
Cerilliant

Generated: December 17, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 203112

« Back to Dashboard

NDA 203112 describes QUININE SULFATE, which is a drug marketed by Amneal Pharms, Lupin Ltd, Mylan Pharms Inc, Riconpharma Llc, and Teva Pharms, and is included in five NDAs. It is available from six suppliers. Additional details are available on the QUININE SULFATE profile page.

The generic ingredient in QUININE SULFATE is quinine sulfate. There are twelve drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the quinine sulfate profile page.

Summary for 203112

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Antiparasitics
Formulation / Manufacturing:see details

Pharmacology for NDA: 203112

Medical Subject Heading (MeSH) Categories for 203112

Suppliers and Packaging for NDA: 203112

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
QUININE SULFATE quinine sulfate CAPSULE;ORAL 203112 ANDA Lupin Pharmaceuticals, Inc. 68180-560 68180-560-06 30 CAPSULE in 1 BOTTLE (68180-560-06)
QUININE SULFATE quinine sulfate CAPSULE;ORAL 203112 ANDA Lupin Pharmaceuticals, Inc. 68180-560 68180-560-03 1000 CAPSULE in 1 BOTTLE (68180-560-03)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength324MG
Approval Date:Apr 24, 2015TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Cipla
US Department of Justice
Julphar
Deloitte
US Army
Fuji
Daiichi Sankyo
Federal Trade Commission
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot